FDA Adverse Event Injury Summary report: N

RENU (UNKNOWN TYPE)

MDR report key: 781386 · Received November 13, 2006

Report

Report Number
1313525-2006-00553
Event Type
Injury
Date Received
November 13, 2006
Date of Event
June 29, 2005
Report Date
April 13, 2006
Manufacturer
BAUSCH & LOMB, INC.
Product Code
LPN
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

BAUSH & LOMB IS UNABLE TO COMPLETE AN INVESTIGATION OF THIS COMPLAINT, SINCE NO PRODUCT WAS RETURNED, AND NO LOT NUMBER WAS PROVIDED. HOWEVER, THE COMPANY DID INITIATE A BROADER INVESTIGATION OF REPORTED FUSARIUM KERATITIS EVENTS THAT EVALUATED THE MANUFACTURING FACILITY ENVIRONMENTAL RECORDS, A REVIEW OF BATCH RECORDS AND TESTING OF RETAIN SAMPLES FOR NUMEROUS PRODUCED PRODUCT LOTS. ALL OF THE RECORDS INDICATE THERE WERE NO ANOMALIES THAT COULD HAVE BEEN RELATED TO REPORTED FUSARIUM KERATITIS, THERE WERE NO FUSARIUM RECOVERIES FROM THE FACILITY ENVIRONMENTAL MONITORING PROGRAM OF ASEPTIC PROCESSING AREAS, AND ALL PRODUCT EVALUATED MET RELEASE STERILITY CRITERIA. WHERE PRODUCT RETAIN SAMPLE TESTING WAS COMPLETED ALL CHEMICAL AND BIOCIDAL PERFORMANCE CRITERIA WERE EFFECTIVE AGAINST MICROBIAL CHALLENGES AS REQUIRED.

Description of Event or Problem · 1

A OPTHALMOLOGIST REPORTED THAT A FEMALE PT DEVELOPED FUSARIUM KERATITIS IN THE RIGHT EYE WHILE USING RENU (UNKNOWN TYPE). THE INITIAL ONSET OF THE PT'S SYMPTOMS BEGAN IN 2006. THE PT WAS TREATED WITH HYSTATIN AND ORAL ANTIFUNGAL MEDICATIONS WITHOUT RESPONSE. PT SUBSEQUENTLY UNDERWENT A PENETRATING KERATOPLASTY 6-8 WEEKS AFTER ONSET. THE PT HAD GOOD POST-OPERATIVE RECOVERY. HER VISUAL ACUITY HAS RETURNED, BUT MAY BE LIMITED DUE TO PROGRESSIVE CATARACTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RENU (UNKNOWN TYPE) MULTI-PURPOSE SOLUTION FOR SOFT CONTACT LENSES LPN BAUSCH & LOMB, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNKNOWN Required Intervention